The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …
Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
G Garcia‐Manero - American journal of hematology, 2023 - Wiley Online Library
Disease overview The myelodysplastic syndromes (MDS) are a very heterogeneous group
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …
within a collaboration between the World Health Organization (WHO), the Society for …
Current challenges and unmet medical needs in myelodysplastic syndromes
U Platzbecker, AS Kubasch, C Homer-Bouthiette… - Leukemia, 2021 - nature.com
Myelodysplastic syndromes (MDS) represent a heterogeneous group of myeloid neoplasms
that are characterized by ineffective hematopoiesis, variable cytopenias, and a risk of …
that are characterized by ineffective hematopoiesis, variable cytopenias, and a risk of …
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆
P Fenaux, D Haase, V Santini, GF Sanz… - Annals of …, 2021 - annalsofoncology.org
Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …
predominating in the elderly, characterised by ineffective haematopoiesis leading to blood …
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
G Garcia‐Manero, KS Chien… - American journal of …, 2020 - Wiley Online Library
Disease overview The myelodysplastic syndromes (MDS) are a very heterogeneous group
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes
Abstract The Molecular International Prognostic Scoring System (IPSS-M) is a novel risk
stratification model for myelodysplastic syndromes (MDS) that builds on the IPSS and IPSS …
stratification model for myelodysplastic syndromes (MDS) that builds on the IPSS and IPSS …
The International Consensus Classification of myelodysplastic syndromes and related entities
Abstract The International Consensus Classification (ICC) of myeloid neoplasms and acute
leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed …
leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed …
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)
F Nguyen-Khac, A Bidet, A Daudignon… - Leukemia, 2022 - nature.com
Karyotype complexity has major prognostic value in many malignancies. There is no
consensus on the definition of a complex karyotype, and the prognostic impact of karyotype …
consensus on the definition of a complex karyotype, and the prognostic impact of karyotype …
[HTML][HTML] Hematopoietic cell transplantation in the management of myelodysplastic syndrome: an evidence-based review from the American Society for Transplantation …
Z DeFilipp, SO Ciurea, C Cutler, M Robin… - … and Cellular Therapy, 2023 - Elsevier
The sole curative therapy for myelodysplastic syndrome (MDS) is allogeneic hematopoietic
cell transplantation (HCT). Here this therapeutic modality is reviewed and critically evaluated …
cell transplantation (HCT). Here this therapeutic modality is reviewed and critically evaluated …